المؤلفون: Julien Mazieres, Balazs Halmos, David Vicente, Ali Tafreshi, Silvia Novello, Terufumi Kato, Bilal Piperdi, Jonathan Wilson, Mahmut Gumus, Jerónimo Rodríguez-Cid, Ki Hyeong Lee, Filiz Çay Şenler, Dariusz M. Kowalski, Shunichi Sugawara, Ying Cheng, Andrea Fülöp, Luis Paz-Ares, Keynote Investigators, Barbara Hermes, Alexander Luft, Gregory M. Lubiniecki, Tibor Csőszi, Xiaodong Li

المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Université Le Havre Normandie (ULH), Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Université Le Havre Normandie (ULH), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)

المصدر: Transl Lung Cancer Res
The New England Journal of Medicine, 379, 2040-2051
The New England Journal of Medicine, 379, 21, pp. 2040-2051
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (21), pp.2040-2051. ⟨10.1056/NEJMoa1810865⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Lung Neoplasms, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Programmed Cell Death 1 Receptor, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Double-Blind Method, Female, Humans, Intention to Treat Analysis, Middle Aged, Paclitaxel, Progression-Free Survival, Survival Analysis, Pembrolizumab, chemistry.chemical_compound, 0302 clinical medicine, Monoclonal, 80 and over, Non-Small-Cell Lung, Humanized, General Medicine, 3. Good health, Editorial Commentary, 030220 oncology & carcinogenesis, medicine.medical_specialty, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Antibodies, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Progression-free survival, Lung cancer, Survival analysis, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, 030104 developmental biology, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b08d70d621daefa6515103b791d7d01Test
https://hdl.handle.net/10668/13017Test

المساهمون: David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, David Vicente, David Planchard, Luis Paz-Ares, Johan F Vansteenkiste, Marina C Garassino, Rina Hui, Xavier Quantin, Andreas Rimner, Yi-Long Wu, Mustafa Özgüroğlu, Ki H Lee, Terufumi Kato, Maike de Wit, Takayasu Kurata, Martin Reck, Byoung C Cho, Suresh Senan, Jarushka Naidoo, Helen Mann, Michael Newton, Piruntha Thiyagarajah, Scott J Antonia, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal / adverse effects, Carcinoma, Non-Small-Cell Lung* / drug therapy, Chemoradiotherapy, Disease Progression, Humans, Lung Neoplasms* / drug therapy

العلاقة: JOURNAL OF CLINICAL ONCOLOGY; J01331; OAK-2022-03288; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189536Test; T202202918; JOURNAL OF CLINICAL ONCOLOGY, Vol.40(12) : 1301-1311, 2022-04

الإتاحة: https://doi.org/10.1200/JCO.21.01308Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/189536Test

المساهمون: Corinne Faivre-Finn, David Vicente, Takayasu Kurata, David Planchard, Luis Paz-Ares, Johan F Vansteenkiste, David R Spigel, Marina C Garassino, Martin Reck, Suresh Senan, Jarushka Naidoo, Andreas Rimner, Yi-Long Wu, Jhanelle E Gray, Mustafa Özgüroğlu, Ki H Lee, Byoung C Cho, Terufumi Kato, Maike de Wit, Michael Newton, Lu Wang, Piruntha Thiyagarajah, Scott J Antonia, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Chemoradiotherapy, Humans, Lung Neoplasms* / drug therapy, Durvalumab, Locally advanced NSCLC, Overall survival, PACIFIC, Progression-free survival

العلاقة: JOURNAL OF THORACIC ONCOLOGY; J01909; OAK-2021-05144; https://ir.ymlib.yonsei.ac.kr/handle/22282913/184740Test; T202103546; JOURNAL OF THORACIC ONCOLOGY, Vol.16(5) : 860-867, 2021-05

الإتاحة: https://doi.org/10.1016/j.jtho.2020.12.015Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/184740Test

المساهمون: Jhanelle E Gray, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki Hyeong Lee, Byoung Chul Cho, David Planchard, Luis Paz-Ares, Corinne Faivre-Finn, Johan F Vansteenkiste, David R Spigel, Catherine Wadsworth, Maria Taboada, Phillip A Dennis, Mustafa Özgüroğlu, Scott J Antonia, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / pathology, Chemoradiotherapy, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / pathology, Neoplasm Staging, Durvalumab, NSCLC, Overall survival, PACIFIC, Three-year update

العلاقة: JOURNAL OF THORACIC ONCOLOGY; J01909; OAK-2022-03876; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190213Test; T9992020438; JOURNAL OF THORACIC ONCOLOGY, Vol.15(2) : 288-293, 2020-02

الإتاحة: https://doi.org/10.1016/j.jtho.2019.10.002Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190213Test

المساهمون: Luis Paz-Ares, Tae Min Kim, David Vicente, Enriqueta Felip, Dae Ho Lee, Ki Hyeong Lee, Chia-Chi Lin, Maria Jose Flor, Massimo Di Nicola, Rosa Maria Alvarez, Isabelle Dussault, Christoph Helwig, Laureen S Ojalvo, James L Gulley, Byoung Chul Cho, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung* / drug therapy, Humans, Lung Neoplasms* / drug therapy, Transforming Growth Factor beta, Bintrafusp alfa, M7824, TGF-beta, PD-L1, NSCLC

العلاقة: JOURNAL OF THORACIC ONCOLOGY; J01909; OAK-2022-03669; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190060Test; T9992020282; JOURNAL OF THORACIC ONCOLOGY, Vol.15(7) : 1210-1222, 2020-07

الإتاحة: https://doi.org/10.1016/j.jtho.2020.03.003Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190060Test

المساهمون: Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit, Byoung C Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young-Chul Kim, Christos S Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E Gray, Luis Paz-Ares, Javier de Castro Carpeño, Corinne Faivre-Finn, Martin Reck, Johan Vansteenkiste, David R Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A Dennis, Mustafa Özgüroğlu, PACIFIC Investigators, Cho, Byoung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal / administration & dosage, Monoclonal / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / mortality, Non-Small-Cell Lung / radiotherapy, Chemoradiotherapy, Female, Humans, Infusions, Intravenous, Intention to Treat Analysis, Kaplan-Meier Estimate, Lung Neoplasms / drug therapy, Lung Neoplasms / mortality, Lung Neoplasms / radiotherapy, Male, Middle Aged, Survival Rate

العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2022-02149; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188947Test; T999201837; NEW ENGLAND JOURNAL OF MEDICINE, Vol.379(24) : 2342-2350, 2018-12

الإتاحة: https://doi.org/10.1056/NEJMoa1809697Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/188947Test